ZYDUSWELL Zydus Wellness Q1 FY26 results (Apr–Jun 2025) and concall
Zydus Wellness reported a mixed Q1 FY26, with consolidated net sales growing 2.2% to ₹8,577 million, but PAT declining 13.4% due to non-cash items. While seasonal brands faced headwinds from unseasonal rains, the company achieved strong double-digit growth excluding these. Gross margins saw a marginal 73 bps decline, but the company returned to a net cash positive position, reinforcing its financial strength and long-term growth strategies.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 493 | 462 | 913 | 861 |
| EBITDA | 20 | 15 | 190 | 156 |
| Net profit | 21 | 6 | 172 | 128 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
